About Tesis Labs
Tesis Labs is a company based in Phoenix (United States) founded in 2021 by Divyen Patel. Tesis Labs has raised $20 million across 1 funding round from investors including Xcellerant Ventures. Tesis Labs has completed 1 acquisition, including Genome Explorations. Tesis Labs offers products and services including Cancer Genomics Panel, Cardiovascular Panel, Diabetes Panel, and Neurology Panel. Tesis Labs operates in a competitive market with competitors including Agiliti, eWeLL Co, Affordable Care, Althea and ARCH, among others.
- Headquarter Phoenix, United States
- Founders Divyen Patel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series B
Oct 05, 2021
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tesis Labs
Tesis Labs offers a comprehensive portfolio of products and services, including Cancer Genomics Panel, Cardiovascular Panel, Diabetes Panel, and Neurology Panel.
Identifies genetic changes related to cancer diagnosis.
Detects genetic predictors for heart disease conditions.
Analyzes genes linked to diabetes and related risks.
Examines genetic factors in neurological disorders like Alzheimer's.
Funding Insights of Tesis Labs
Tesis Labs has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tesis Labs
Tesis Labs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Xcellerant Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Xcellerant Ventures is focused on funding healthcare innovation.
|
Locked | Locked | Locked |
Investor details for Tesis Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tesis Labs
Tesis Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genome Explorations.
Investment portfolio details for Tesis Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Laboratory services in genomics
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Tesis Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Tesis Labs
Detailed financials for Tesis Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tesis Labs Comparisons
Peer comparison for Tesis Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tesis Labs
Tesis Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agiliti, eWeLL Co, Affordable Care, Althea and ARCH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical equipment management services are provided by Agiliti.
|
|
| Locked | Locked | Locked |
Provider of electronic medical record services
|
|
| Locked | Locked | Locked |
Medical equipment support services are provided nationwide.
|
|
| Locked | Locked | Locked |
Pharmaceutical-grade medicinal cannabis is produced, supplied, and exported.
|
|
| Locked | Locked | Locked |
Digital solutions for gynecology and fertility treatments are provided by ARCH.
|
Detailed competitors of Tesis Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tesis Labs
Complete news archive for Tesis Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tesis Labs
Tesis Labs was founded in 2021.
Tesis Labs is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
Ron King is the current CEO of Tesis Labs.
Tesis Labs is a funded company, having raised a total of $20M across 1 funding round to date.
Tesis Labs was founded in 2021 and is headquartered in Phoenix, United States. Operations focus on the biosciences sector, where a medical platform is utilized to conduct testing services and supply related equipment. Core activities encompass support for healthcare testing processes and equipment distribution, serving needs in medical diagnostics and research applications across the region.
Tesis Labs's top competitors include Agiliti, TEAM Technologies and Hospithera.
Tesis Labs offers Cancer Genomics Panel, Cardiovascular Panel, Diabetes Panel, and Neurology Panel.
Tesis Labs has made 1 acquisition, including Genome Explorations.
Tesis Labs has 1 investor. Key investors include Xcellerant Ventures.